Fondaparinux sodium identification
USP/1282718 - United States Pharmacopeia (USP) Reference Standard
Synonym: Fondaparinux sodium; Fondaparin sodium; Methyl O-
CAS Number: 114870-03-0
Empirical Formula (Hill Notation): C31H43N3O49S8 · 10Na
Molecular Weight: 1728.08
Linear Formula: C31H43N3O49S8 · 10Na
Product Type: Chemical
API family | fondaparinux |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C31H53N3O49S8.10Na/c1- |
InChI key | XEKSTYNIJLDDAZ-JASSWCPGSA |
manufacturer/tradename | USP |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | Fondaparinux sodium is an antithrombotic anticoagulant, a Factor Xa inhibitor. Fondaparinux sodium is chemically related to low molecular weight heparins. Its pentasaccharide structure corresponds to the antithrombin III (ATIII) binding site of heparin. Fondaparinux sodium binding at this site potentiates the natural inhibitory effect of ATIII against factor Xa by a factor of approximately 300, which results in inhibition of thrombin generation. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
Other Notes: | This product is part of the USP Biologics program. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |